Ampio Pharmaceuticals Announces Participation at the UBS Global Healthcare
GREENWOOD VILLAGE, Colo., May 13, 2013
GREENWOOD VILLAGE, Colo., May 13, 2013 /PRNewswire/ -- Ampio Pharmaceuticals,
Inc. (NASDAQ: AMPE) today announced that it will present at the following
oUBS Global Healthcare Conference, on Wednesday, May 22 2013 at 12:00 p.m.
Ampio will webcast this management presentation, and the presentation may be
accessed through the Company's website, www.ampiopharma.com, on the "Events
and Presentations' page. An archived version of the presentation will be
available for 180 days.
About Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company focused on the
rapid development of therapies to treat prevalent inflammatory conditions for
which there are limited treatment options. It aims to provide medicines to
improve the health and quality of life of patients with minimal side effects.
Ampio is developing compounds that decrease inflammation by 1) inhibition of
specific pro-inflammatory compounds by affecting specific pathways at the
protein expression and at the transcription level or 2) activation of a
specific phosphatase or depletion of the available phosphate needed for the
inflammation process. For more information visit: www.ampiopharma.com.
Director of Investor Relations
Ampio Pharmaceuticals, Inc.
Direct (720) 437-6530
SOURCE Ampio Pharmaceuticals, Inc.
Press spacebar to pause and continue. Press esc to stop.